10.09
Schlusskurs vom Vortag:
$10.25
Offen:
$10.25
24-Stunden-Volumen:
1.28M
Relative Volume:
0.58
Marktkapitalisierung:
$761.11M
Einnahmen:
$3.64M
Nettoeinkommen (Verlust:
$-87.37M
KGV:
-2.4551
EPS:
-4.11
Netto-Cashflow:
$-86.46M
1W Leistung:
+3.17%
1M Leistung:
+25.03%
6M Leistung:
+65.14%
1J Leistung:
+83.79%
Verastem Inc Stock (VSTM) Company Profile
Firmenname
Verastem Inc
Sektor
Branche
Telefon
(781) 292-4200
Adresse
117 KENDRICK STREET, NEEDHAM, MA
Vergleichen Sie VSTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VSTM
Verastem Inc
|
10.11 | 772.03M | 3.64M | -87.37M | -86.46M | -4.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verastem Inc Stock (VSTM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-04-10 | Eingeleitet | Jefferies | Buy |
| 2025-03-24 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-31 | Bestätigt | BTIG Research | Buy |
| 2024-09-30 | Eingeleitet | Guggenheim | Buy |
| 2023-11-21 | Fortgesetzt | BTIG Research | Buy |
| 2023-09-27 | Eingeleitet | B. Riley Securities | Buy |
| 2023-06-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-09-07 | Fortgesetzt | Alliance Global Partners | Buy |
| 2022-04-29 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-04-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-09 | Eingeleitet | Truist | Buy |
| 2021-07-01 | Eingeleitet | Alliance Global Partners | Buy |
| 2021-05-24 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-06-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-07-13 | Eingeleitet | BTIG Research | Buy |
| 2018-05-02 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-09-07 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2017-03-24 | Bestätigt | H.C. Wainwright | Buy |
| 2015-09-29 | Herabstufung | Cantor Fitzgerald | Buy → Hold |
| 2015-09-29 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-09-29 | Herabstufung | Jefferies | Buy → Hold |
| 2015-09-29 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-09-28 | Herabstufung | Mizuho | Buy → Neutral |
| 2015-09-28 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-05-12 | Bestätigt | UBS | Buy |
| 2015-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-01-23 | Bestätigt | ROTH Capital | Buy |
| 2014-07-08 | Fortgesetzt | Oppenheimer | Perform |
| 2014-02-11 | Eingeleitet | Mizuho | Buy |
Alle ansehen
Verastem Inc Aktie (VSTM) Neueste Nachrichten
Is Verastem Inc a good long term investmentMACD Trading Signals & Free Expert Guidance For Growth - earlytimes.in
Will Verastem Inc stock benefit from green energy trends2025 Trading Volume Trends & Verified Stock Trade Ideas - BỘ NỘI VỤ
132,444 Shares in Verastem, Inc. $VSTM Purchased by Panagora Asset Management Inc. - MarketBeat
With Verastem Stock Surging, Have You Considered The Downside? - Trefis
Is Verastem Stock Built to Withstand a Pullback? - Trefis
Aug Reactions: Why Verastem Inc stock appeals to dividend seekers2025 Sector Review & Technical Pattern Based Signals - BỘ NỘI VỤ
Verastem (NASDAQ:VSTM) CEO Dan Paterson Sells 2,000 Shares - MarketBeat
Does Verastem Inc. (2VSA) stock trade below intrinsic valueTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Will Verastem Inc. (2VSA) stock outperform energy sector in 2025Market Activity Recap & Accurate Technical Buy Alerts - Newser
Will Verastem Inc. (2VSA) stock sustain uptrend momentumPortfolio Growth Summary & Real-Time Buy Signal Alerts - Newser
How supply shortages influence Verastem Inc. (2VSA) stock2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Why Verastem Inc. stock appeals to dividend seekersTrend Reversal & Safe Investment Capital Preservation Plans - Newser
Verastem Inc. R (2VSA.DU) stock price, news, quote and history - Yahoo Finance UK
Insider Sell: Dan Paterson Sells 6,000 Shares of Verastem Inc (V - GuruFocus
Verastem President and CEO Dan Paterson Sells 6,000 Shares - TradingView
CEO Paterson Sells 6,000 ($60.6K) Of Verastem Inc [VSTM] - TradingView
XTX Topco Ltd Purchases New Position in Verastem, Inc. $VSTM - MarketBeat
Verastem (VSTM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Verastem (NASDAQ:VSTM) CEO Sells $21,580.00 in Stock - MarketBeat
VSTM SEC FilingsVerastem 10-K, 10-Q, 8-K Forms - Stock Titan
Verastem Inc (VSTM) President and CEO Dan Paterson Sells 6,000 S - GuruFocus
Verastem, Inc. $VSTM Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat
Verastem (NASDAQ:VSTM) Director Sells $85,500.00 in Stock - MarketBeat
Aug Selloffs: Is Verastem Inc. stock a defensive play in 20252025 Pullback Review & Entry and Exit Point Strategies - BỘ NỘI VỤ
EBITDA per share of Verastem, Inc. – TRADEGATE:2VSA - TradingView
Insider Selling: Verastem (NASDAQ:VSTM) Director Sells 6,250 Shares of Stock - MarketBeat
Verastem Announces Positive Data From Cancer Trial Conducted By Partner: Retail Turns Bullish - MSN
Verastem Executives Engage in Stock Transactions - TradingView
Dir Bunn Sells 6,250 ($62.5K) Of Verastem Inc [VSTM] - TradingView
[Form 4] Verastem, Inc. Insider Trading Activity - Stock Titan
CEO Paterson Sells 6,000 ($60K) Of Verastem Inc [VSTM] - TradingView
Deep Track Capital, LP Acquires Significant Stake in Verastem Inc - GuruFocus
Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference - MarketScreener
United StatesMintz Advises On Verastem Oncology’s $103 Million Public Offering - Mondaq
Understanding Momentum Shifts in (VSTM) - news.stocktradersdaily.com
Dir Kauffman Files To Sell 8,550 Of Verastem Inc [VSTM] - TradingView
Is Verastem Inc. (2VSA) stock considered safe havenIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
How interest rate cuts could boost Verastem Inc. stock2025 Trade Ideas & Stock Portfolio Risk Management - newser.com
Verastem (NASDAQ:VSTM) Lowered to Hold Rating by Zacks Research - MarketBeat
Balyasny Asset Management L.P. Increases Stake in Verastem Inc. - GuruFocus
Verastem Oncology Prices $90 Million Public Offering - Global Legal Chronicle
Verastem Inc. (VSTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is it too late to sell Verastem Inc.2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Will Verastem Inc. stock deliver better than expected guidanceJuly 2025 Final Week & Accurate Buy Signal Alerts - newser.com
Institutional scanner results for Verastem Inc.July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com
Is Verastem Inc. stock cheap at current valuationPortfolio Return Summary & Daily Entry Point Trade Alerts - newser.com
Is Verastem Inc. stock supported by strong cash flowsTrade Risk Summary & Low Drawdown Trading Strategies - newser.com
Will Verastem Inc. stock remain a Wall Street favorite2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Is Verastem Inc. (2VSA) stock undervalued after correction2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Verastem Inc. stock daily chart insightsPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
How supply chain issues affect Verastem Inc. stockWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com
Finanzdaten der Verastem Inc-Aktie (VSTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):